Navigation Links
Evonik and Genedata Broaden Their Collaboration with the Genedata Selector Biotechnology Data Management Platform
Date:9/17/2013

Basel, Switzerland (PRWEB) September 17, 2013

Genedata, a leading provider of advanced software solutions for industrial, agricultural, drug discovery, and life science research, today announced that Evonik is extending its collaboration with Genedata. Building on its long-standing partnership with Genedata, Evonik is using the Genedata fully integrated offering that includes Genedata Selector™ for the management and analysis of strain information, scientific data analysis consulting provided by Genedata bioinformatics experts, and specialized IT services. The integrated solution from Genedata will help Evonik advance its industry diversification projects and strengthen the return on its strategic biotechnology investments.

“New, data-intensive and omics-based technologies are catalysts for innovation in the health and food industries,” noted Dr. Ralf Kelle, vice president of R&D Bioproducts for the Evonik Health and Nutrition business unit. “Genedata – with its domain expertise in data analysis and management – helps us get maximum value from our data. More importantly, our relationship with Genedata allows us to benefit from their innovative solutions, which contribute to the success of our resource-efficient and sustainable biotechnology research.”

Beyond Software – Scientific Data Analysis Consulting & Specialized IT Services
Evonik has successfully used Genedata Selector to manage, visualize, and analyze complete genomes of production strain collections with a focus on mutation analysis and deciphering complex genotype-phenotype relationships. Genedata Selector accelerates difficult strain optimization projects for the production of bio-based chemicals, nutritional proteins, food and feed additives, and cosmetics ingredients.

Now, in addition to Genedata Selector enterprise software, Evonik will also use Genedata scientific data analysis consulting services. Based on in-depth and extensive experience in the industrial biotechnology field, these value-added services help to eliminate resource bottlenecks, provide cost-effective support for strategically important projects, and deliver valuable results quickly and efficiently.

Addressing the complete life cycle of R&D projects – from early-stage feasibility studies to late-stage product development – Genedata scientific data analysis consulting delivers:

  • proprietary genome annotations, including gene calling and functional annotations up to the pathway level (for prokaryotes as well as eukaryotes);
  • production strain comparisons, including interpretations of biological effects of variants (e.g. on enzyme activities);
  • cellular signaling network reconstructions for proprietary strains, based on expression and regulatory sequence data;
  • biomarkers, based on omics, NGS, pathway, and functional annotation data; and
  • statistical expression analysis reports (e.g. of microarray or RNAseq data).

In the enterprise R&D environment, Genedata specialized IT services ensure server availability and infrastructure stability for high-performance server infrastructures. These services, which empower researchers to focus more on scientific discovery, include:

  • hosting and remote server maintenance;
  • software and database integration services; and
  • data migration and integration services, including public domain genome release monitoring.

“We are proud of our long-standing and successful partnership with Evonik, a world leader in specialty chemicals,” noted Dr. Othmar Pfannes, CEO of Genedata. “Their adoption of the Genedata Selector application suite, coupled with our scientific consulting and professional IT services, serves as an industry model for other customers in industrial biotechnology research who want to leverage the full advantage of our bioinformatics expertise to achieve their business objectives.”

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com

Read the full story at http://www.prweb.com/releases/2013/9/prweb11088626.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening
2. Genedata Screener Extends Support for High-Throughput Thermofluor Assays
3. Genedata at ESACT Announces Expansion Into Biopharma Process Development
4. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
5. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
6. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
7. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
8. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
9. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
10. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
11. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" ... by its major shareholders, Clean Technology Fund I, LP ... States based venture capital funds which together ... (on a fully diluted, as converted basis), that they ... their entire equity holdings in Biorem to TUS Holdings ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:6/22/2016)... On Monday, the Department of Homeland Security (DHS) issued ... the Biometric Exit Program. The Request for Information (RFI), ... that CBP intends to add biometrics to confirm when ... , in order to deter visa overstays, to ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/20/2016)... 20, 2016 Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring announced ... it has secured the final acceptance by all ... Managed Access Systems (MAS) installed. Furthermore, Securus will ... be installed by October, 2016. MAS distinguishes between ...
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
Breaking Biology News(10 mins):